期刊文献+

SLE患者血清IL-17、IL-6相关性研究 被引量:3

Study on relationship between serum IL-17,IL-6 levels and SLE patients
原文传递
导出
摘要 目的:探讨系统性红斑狼疮(SLE)患者血清中的IL-17、IL-6水平及其与疾病活动性之间的相关性。方法:选取40例SLE患者和40例正常对照者,采用ELISA法测试其血清IL-17和IL-6,仪器法检测ESR,免疫比浊法检测血清C_3、C_4、IgG、IgA、IgM。结果:SLE患者组的血清补体C_3、C_4、IgG、IgM、IL-17、IL-6水平与正常对照组比较差异有统计学意义;患者组血清补体C_3水平与疾病活动指数(SLEDAI)呈负相关,IL-17、IL-6水平与SLEDAI呈正相关。同时发现IL-17与IL-6之间、IL-17/IL-6与SLEDAI之间也分别存在相关性。结论:IL-17、IL-6可能在SLE的发生和发展过程中起到较为重要的作用。 Objective:To discuss the relationship between the levels of and system lupus erythematosus(SLL)activities.Method:Forty SLE patients and 40 healthy people were selected.The levels of serum IL-17 and IL-6were detected by ELISA,ESR was detected by equipment and the proteins including C_3,C_4,IgG,IgA and IgM were detected by turbidimetric inhibition immuno assay,Result:The serum levels of C_3,C_4,IgG,IgM,IL-17 and IL-6 of SLE patients were obvious differently from the healthy control.The serum C_3 level in SLE patients was negatively correlated with the SLEDAI.Both IL-17 and IL-6 were positively correlated with the SLEDAI.And a correlation was observed between serum IL-17 and IL-6 or serum IL-17/IL-6 and SLEDAI.Conclusion:IL-17 and IL-6 may play an important role during the course of SLE procession and development.
出处 《临床血液学杂志(输血与检验)》 CAS 2015年第6期1015-1018,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 系统性红斑狼疮 白介素17 白介素6 systemic lupus erythem atosus IL-17 IL-6
  • 相关文献

参考文献9

  • 1Fabien B Vincent, Melissa Northcott, Alberta Hoi,et al. Clinical associations of serum interleukin-17 in systemic lupus erythematosus [J ]. Arthritis Res T- her,2013, 15:97-105.
  • 2黄华,陈勇,楼燕如,黄娴倩,忻霞菲,周丽,王庭辉,覃文.Th17/Treg在系统性红斑狼疮患者中的探讨[J].现代实用医学,2014,26(9):1078-1079. 被引量:5
  • 3Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997,40:17-25.
  • 4Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts [J]. Clin Explmmuno12009, 157:209-215.
  • 5Wong CK,Lit LC,Tam LS,et al. Hyper production of IL-23 and IL-17 in patients with systemic lupus ery- thematosus:implications for Thl7-mediated inflamma- tion in autoimmunity [ J ]. Clin Immunol, 2008, 127 .. 385-393.
  • 6Ripley BJ, Goncalves B, Isenberg DA, et al. Raised leveh Of IL-6 in systemic lupus erythematosus corre- late with anaemia[J]. Ann Rheum Dis, 2005, 64: 849-853.
  • 7朱静,龙武彬,程佳,吴侗.系统性红斑狼疮患者外周血IL-6与疾病活动性的关系研究[J].四川医学,2013,34(5):592-593. 被引量:6
  • 8黄志芳,李新伦,李红霞,伦立德.Th17细胞及白介素-17在系统性红斑狼疮发病中的作用[J].空军医学杂志,2014,30(1):28-30. 被引量:13
  • 9Lesiak A, Sysa A, Narbu J, et al. Prainflammatory cy- tokines in active Lupus erythematosus patients[J]. PrzeglLek, 2005,62 : 838- 842.

二级参考文献26

  • 1Klashman DJ,Martin RA, Martinez-Maza O,et al. In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B ceils [ J ]. Arthritis Rheum, 1991,34 ( 3 ) : 276 - 286.
  • 2Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupuse rythematosus[ J ]. Arthritis Rheum, 1997,40 (9) : 1725.
  • 3Lesiak A, Sysa A, Narbu J, et al. Proin/lammatory eytokines in active lupus erythematosus patients [ J ]. Przegl Lek,2005,62 (9) :838 - 842.
  • 4Tackey E,Eipsky PE, Illei GG, et al. Rationale for interleukin-6 blockade in systemic lupus erythematosus[J]. Lupus, 2004, 13 (5) : 339 - 343.
  • 5H Cash, M Relle, J Menke. et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Fas Iprmiee:the IL-6 pathway as a new therapeutic target in treatment of autoim-mune kidney disease in sys- temic lupus erythematosus[ J ]. The Journal of Rheumatology, 2010, 37(I): 60-70.
  • 6M Mihara, N Takagi, Y Takeda, el al. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/WFI mice[ J ]. Clinical & Experimental Immunology, 1998,112 ( 3 ) : 397 - 402.
  • 7Shirota Y,Yarboro C, Fischer R,et al. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus[ J]. Ann Rheum Dis,2012, 8 ( 2 ) : 1.
  • 8G Gromtal, I Gunnarsson, J Ronnelid, et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus [ J ]. Clinical and Experimental Rheumatology ,2000,18 ( 5 ) :565 - 570.
  • 9Brugos B, Vineze Z,Sipka S, et al. Serum and urinary eytokine level of patients [ J ]. Pharmazie,2012,67 ( 5 ) :411 - 413.
  • 10Kirkham BW, Lassere MN, Edmonds JP, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis:a two-year prospective study (the DAMAGE study cohort) [J]. Arthritis Rheum, 2006, 54 (4):1122-1131.

共引文献21

同被引文献28

  • 1王玉辉,侯沪,郭淼.几种免疫学指标联合检测对系统性红斑狼疮的诊断价值[J].中国热带医学,2005,5(5):1014-1015. 被引量:3
  • 2Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes[J]. Arthritis Rheum,2005,52(2):514- 521.
  • 3Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications and its modulation[J]. Front Biosci, 2008, 13(3) :985- 994.
  • 4Katsiari CG, Tsokos GC. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus[J]. Autoimmun Rev, 2006,5 (2):118-121.
  • 5Harigai M, Kawamoto M, Hara M, et al. Excessive production of IFN- gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell- activating factor, rl'NF ligand superfamily-13B[J]. J Immunol, 2008, 181(3):2211-2219.
  • 6Willis R, Seif A, MeGwiu G Jr, et al. Effect of Hydroxychloroquine Treatment on Pro-inflammatory Cytokines and Disease Activity in SLE Patients: Data from LUMINA (LXXV), a Multiethnic US Cohort [J]. Lupus, 2012,21 (8):830-835.
  • 7Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus[J]. Annals of the Rheumatic Diseases, 2006,65 (2):209-215.
  • 8Tucci M, Lombardi L, Richards HB, et al. Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis[J]. Clin Exp Immunol, 2008,154(2):247-254.
  • 9Oldblatt F, Isenberg DA. New therapies for systemic lupus erythematosus[J]. Clin Exp Immunol, 2005,140(2):205-212:.
  • 10Juan Peng,Xuexian O Yang,Seon Hee Chang,Jiong Yang,Chen Dong.IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation[J].Cell Research,2010,20(1):62-71. 被引量:31

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部